author-photo

Christopher J. Walker

Ohio State University

231

Papers

1669

Citations

Citation Trend

Filter By

Papers (167) Sort By

Journal Conference Others

RTID-08. MACHINE LEARNING TO UNCOVER SIGNATURES OF VULNERABILITY IN GLIOBLASTOMA UMBRELLA SIGNATURE TRIAL (GUST)

2021 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Remand and Dialogue in Administrative Law

2021 Social Science Research Network
- Christopher J. Walker
- James Saywell
Show All
- Source
- Cite
- Save
Citations (0)
A Phase 1 Clinical Trial of Oral Eltanexor in Patients with Relapsed or Refractory Multiple Myeloma.

2021 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (0)
Effects of weekly selinexor, bortezomib, dexamethasone (XVd) versus standard twice weekly bortezomib and dexamethasone (Vd) on RAS-mutated previously treated multiple myeloma (MM).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Phase 2 Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Constraining Bureaucracy Beyond Judicial Review

2021 Daedalus
- Christopher J. Walker
Show All
- Source
- Cite
- Save
Citations (0)
Congress's Anti-Removal Power

2021 Social Science Research Network
- Aaron L. Nielson
- Christopher J. Walker
Show All
- Source
- Cite
- Save
Citations (0)
Molecular predictors of response to selinexor in advanced unresectable de-differentiated liposarcoma (DDLS).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1061: Characterization of synergistic selinexor combinations with dexamethasone, pomalidomide, elotuzumab, and daratumumab in primary MM cells

2021
Show All
- Source
- Cite
- Save
Citations (0)
White Blood Cell Count (WBC) Levels Are Associated with Molecular Profiles and Are Independent Outcome Predictors in Acute Myeloid Leukemia (AML) Patients (Pts) (Alliance)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)